Cannabinoid Signalling in Immune–Reproductive Crosstalk during Human Pregnancy
Abstract
:1. Introduction
2. Uterine Natural Killer Cells in the Decidua
3. Trophoblasts in the Placenta
4. Interactions between uNK Cells and EVTs
5. ECS Signalling in the Immune System
6. ECS Signalling in the Female Reproductive System
7. Crosstalk between ECS Signalling in the Immune and Reproductive Systems
8. Effects of Maternal Cannabis Use during Pregnancy
9. Therapeutic Applicability of Cannabinoids
10. Synthetic Cannabinoid-Based Drugs: Cesamet, Marinol, Syndros
11. Phytocannabinoid-Containing Drugs: Epidiolex, Sativex
12. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Strowitzki, T.; Germeyer, A.; Popovici, R.; von Wolff, M. The Human Endometrium as a Fertility-Determining Factor. Hum. Reprod. Update 2006, 12, 617–630. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Trundley, A.; Moffett, A. Human Uterine Leukocytes and Pregnancy. Tissue Antigens 2004, 63, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Trowsdale, J.; Betz, A.G. Mother’s Little Helpers: Mechanisms of Maternal-Fetal Tolerance. Nat. Immunol. 2006, 7, 241–246. [Google Scholar] [CrossRef]
- Bulmer, J.N.; Morrison, L.; Longfellow, M.; Ritson, A.; Pace, D. Granulated Lymphocytes in Human Endometrium: Histochemical and Immunohistochemical Studies. Hum. Reprod. 1991, 6, 791–798. [Google Scholar] [CrossRef] [PubMed]
- Lanier, L.L.; Testi, R.; Bindl, J.; Phillips, J.H. Identity of Leu-19 (CD56) Leukocyte Differentiation Antigen and Neural Cell Adhesion Molecule. J. Exp. Med. 1989, 169, 2233–2238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Williams, P.J.; Searle, R.F.; Robson, S.C.; Innes, B.A.; Bulmer, J.N. Decidual Leucocyte Populations in Early to Late Gestation Normal Human Pregnancy. J. Reprod. Immunol. 2009, 82, 24–31. [Google Scholar] [CrossRef] [PubMed]
- Bulmer, J.N.; Williams, P.J.; Lash, G.E. Immune Cells in the Placental Bed. Int. J. Dev. Biol. 2010, 54, 281–294. [Google Scholar] [CrossRef]
- Saito, S.; Nishikawa, K.; Morii, T.; Enomoto, M.; Narita, N.; Motoyoshi, K.; Ichijo, M. Cytokine Production by CD16-CD56bright Natural Killer Cells in the Human Early Pregnancy Decidua. Int. Immunol. 1993, 5, 559–563. [Google Scholar] [CrossRef]
- Jokhi, P.P.; King, A.; Loke, Y.W. Cytokine Production and Cytokine Receptor Expression by Cells of the Human First Trimester Placental-Uterine Interface. Cytokine 1997, 9, 126–137. [Google Scholar] [CrossRef]
- Rieger, L.; Kämmerer, U.; Hofmann, J.; Sütterlin, M.; Dietl, J. Choriocarcinoma Cells Modulate the Cytokine Production of Decidual Large Granular Lymphocytes in Coculture. Am. J. Reprod. Immunol. 2001, 46, 137–143. [Google Scholar] [CrossRef]
- Lash, G.E. Expression of Angiogenic Growth Factors by Uterine Natural Killer Cells during Early Pregnancy. J. Leukoc. Biol. 2006, 80, 572–580. [Google Scholar] [CrossRef]
- Pacher, P.; Bátkai, S.; Kunos, G. The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacol. Rev. 2006, 58, 389–462. [Google Scholar] [CrossRef] [Green Version]
- Lu, H.C.; Mackie, K. Review of the Endocannabinoid System. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 2020, 24, 1–9. [Google Scholar] [CrossRef]
- Devane, W.A.; Hanuš, L.; Breuer, A.; Pertwee, R.G.; Stevenson, L.A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor. Science 1992, 258, 1946–1949. [Google Scholar] [CrossRef]
- Okamoto, Y.; Morishita, J.; Tsuboi, K.; Tonai, T.; Ueda, N. Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners. J. Biol. Chem. 2004, 279, 5298–5305. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cravatt, B.F.; Giang, D.K.; Mayfield, S.P.; Boger, D.L.; Lerner, R.A.; Gilula, N.B. Molecular Characterization of an Enzyme That Degrades Neuromodulatory Fatty-Acid Amides. Nature 1996, 384, 83–87. [Google Scholar] [CrossRef] [PubMed]
- Maccarrone, M. Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years. Front. Mol. Neurosci. 2017, 10, 1–10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sugiura, T.; Kondo, S.; Sukagawa, A.; Nakane, S.; Shinoda, A.; Itoh, K.; Yamashita, A.; Waku, K. 2-Arachidonoylglycerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain. Biochem. Biophys. Res. Commun. 1995. [Google Scholar] [CrossRef] [PubMed]
- Aso, C.; Araki, M.; Ohshima, N.; Tatei, K.; Hirano, T.; Obinata, H.; Kishi, M.; Kishimoto, K.; Konishi, A.; Goto, F.; et al. Protein Purification and Cloning of Diacylglycerol Lipase from Rat Brain. J. Biochem. 2016, 159, 585–597. [Google Scholar] [CrossRef] [Green Version]
- Blankman, J.L.; Simon, G.M.; Cravatt, B.F. A Comprehensive Profile of Brain Enzymes That Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol. Chem. Biol. 2007, 14, 1347–1356. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Baggelaar, M.P.; Maccarrone, M.; van der Stelt, M. 2-Arachidonoylglycerol: A Signaling Lipid with Manifold Actions in the Brain. Prog. Lipid Res. 2018, 71, 1–17. [Google Scholar] [CrossRef]
- Stella, N.; Schweitzer, P.; Plomelli, D. A Second Endogenous’ Cannabinoid That Modulates Long-Term Potentiation. Nature 1997, 388, 773–778. [Google Scholar] [CrossRef] [Green Version]
- Pertwee, R.G. Cannabinoid Pharmacology: The First 66 Years. Br. J. Pharmacol. 2006, 147. [Google Scholar] [CrossRef] [Green Version]
- Matsuda, L.A.; Lolait, S.J.; Brownstein, M.J.; Young, A.C.; Bonner, T.I. Structure of a Cannabinoid Receptor and Functional Expression of the Cloned CDNA. Nature 1990, 346, 561–564. [Google Scholar] [CrossRef]
- Zou, S.; Kumar, U. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Int. J. Mol. Sci. 2018, 19, 833. [Google Scholar] [CrossRef] [Green Version]
- Munro, S.; Thomas, K.L.; Abu-Shaar, M. Molecular Characterization of a Peripheral Receptor for Cannabinoids. Nature 1993, 365, 61–65. [Google Scholar] [CrossRef]
- Turcotte, C.; Blanchet, M.R.; Laviolette, M.; Flamand, N. The CB2 Receptor and Its Role as a Regulator of Inflammation. Cell. Mol. Life Sci. 2016, 73, 4449–4470. [Google Scholar] [CrossRef] [Green Version]
- Zygmunt, P.M.; Petersson, J.; Andersson, D.A.; Chuang, H.H.; Sørgård, M.; Di Marzo, V.; Julius, D.; Högestätt, E.D. Vanilloid Receptors on Sensory Nerves Mediate the Vasodilator Action of Anandamide. Nature 1999, 400, 452–457. [Google Scholar] [CrossRef]
- Sun, Y.; Alexander, S.P.H.; Garle, M.J.; Gibson, C.L.; Hewitt, K.; Murphy, S.P.; Kendall, D.A.; Bennett, A.J. Cannabinoid Activation of PPARα; a Novel Neuroprotective Mechanism. Br. J. Pharmacol. 2007, 152, 734–743. [Google Scholar] [CrossRef] [Green Version]
- Lauckner, J.E.; Jensen, J.B.; Chen, H.Y.; Lu, H.C.; Hille, B.; Mackie, K. GPR55 Is a Cannabinoid Receptor That Increases Intracellular Calcium and Inhibits M Current. Proc. Natl. Acad. Sci. USA 2008, 105, 2699–2704. [Google Scholar] [CrossRef] [Green Version]
- Rajaraman, G.; Simcocks, A.; Hryciw, D.H.; Hutchinson, D.S.; McAinch, A.J. G Protein Coupled Receptor 18: A Potential Role for Endocannabinoid Signaling in Metabolic Dysfunction. Mol. Nutr. Food Res. 2016, 60, 92–102. [Google Scholar] [CrossRef] [PubMed]
- Overton, H.A.; Babbs, A.J.; Doel, S.M.; Fyfe, M.C.T.; Gardner, L.S.; Griffin, G.; Jackson, H.C.; Procter, M.J.; Rasamison, C.M.; Tang-Christensen, M.; et al. Deorphanization of a G Protein-Coupled Receptor for Oleoylethanolamide and Its Use in the Discovery of Small-Molecule Hypophagic Agents. Cell Metab. 2006, 3, 167–175. [Google Scholar] [CrossRef] [Green Version]
- Ibsen, M.S.; Connor, M.; Glass, M. Cannabinoid CB 1 and CB 2 Receptor Signaling and Bias. Cannabis Cannabinoid Res. 2017, 2, 48–60. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Howlett, A.C.; Fleming, R.M. Cannabinoid Inhibition of Adenylate Cyclase. Biochemistry of the Response in Neuroblastoma Cell Membranes. Mol. Pharmacol. 1985, 27, 429–436. [Google Scholar]
- Howlett, A.C.; Qualy, J.M.; Khachatrian, L.L. Involvement of G(i) in the Inhibition of Adenylate Cyclase by Cannabimimetic Drugs. Mol. Pharmacol. 1986, 29, 307–313. [Google Scholar]
- Howlett, A.C.; Johnson, M.R.; Melvin, L.S.; Milne, G.M. Nonclassical Cannabinoid Analgetics Inhibit Adenylate Cyclase: Development of a Cannabinoid Receptor Model. Mol. Pharmacol. 1988, 33, 297–302. [Google Scholar]
- Hampson, A.J.; Grimaldi, M. Cannabinoid Receptor Activation and Elevated Cyclic AMP Reduce Glutamate Neurotoxicity. Eur. J. Neurosci. 2001, 13, 1529–1536. [Google Scholar] [CrossRef]
- Pierce, K.L.; Premont, R.T.; Lefkowitz, R.J. Seven-Transmembrane Receptors. Nat. Rev. Mol. Cell Biol. 2002, 3, 639–650. [Google Scholar] [CrossRef]
- Ruiz, L.; Miguel, A.; Díaz-Laviada, I. Δ9-Tetrahydrocannabinol Induces Apoptosis in Human Prostate PC-3 Cells via a Receptor-Independent Mechanism. FEBS Lett. 1999, 458, 400–404. [Google Scholar] [CrossRef] [Green Version]
- Jiang, S.; Fu, Y.; Williams, J.; Wood, J.A.; Pandarinathan, L.; Avraham, S.; Makriyannis, A.; Avraham, S.; Avraham, H.K. Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells. PLoS ONE 2007, 2, e641. [Google Scholar] [CrossRef]
- Khare, M.; Taylor, A.H.; Konje, J.C.; Bell, S.C. Δ9-Tetrahydrocannabinol Inhibits Cytotrophoblast Cell Proliferation and Modulates Gene Transcription. Mol. Hum. Reprod. 2006, 12, 321–333. [Google Scholar] [CrossRef] [Green Version]
- Galve-Roperh, I.; Chiurchiù, V.; Díaz-Alonso, J.; Bari, M.; Guzmán, M.; Maccarrone, M. Cannabinoid Receptor Signaling in Progenitor/Stem Cell Proliferation and Differentiation. Prog. Lipid Res. 2013, 52, 633–650. [Google Scholar] [CrossRef] [PubMed]
- Kenney, S.P.; Kekuda, R.; Prasad, P.D.; Leibach, F.H.; Devoe, L.D.; Ganapathy, V. Cannabinoid Receptors and Their Role in the Regulation of the Serotonin Transporter in Human Placenta. Am. J. Obstet. Gynecol. 1999, 181, 491–497. [Google Scholar] [CrossRef]
- Habayeb, O.M.H.; Taylor, A.H.; Bell, S.C.; Taylor, D.J.; Konje, J.C. Expression of the Endocannabinoid System in Human First Trimester Placenta and Its Role in Trophoblast Proliferation. Endocrinology 2008, 149, 5052–5060. [Google Scholar] [CrossRef] [Green Version]
- Maia, J.; Midão, L.; Cunha, S.C.; Almada, M.; Fonseca, B.M.; Braga, J.; Gonçalves, D.; Teixeira, N.; Correia-da-Silva, G. Effects of Cannabis Tetrahydrocannabinol on Endocannabinoid Homeostasis in Human Placenta. Arch. Toxicol. 2019, 93, 649–658. [Google Scholar] [CrossRef] [Green Version]
- Costa, M.A. The Endocannabinoid System: A Novel Player in Human Placentation. Reprod. Toxicol. 2016, 61, 58–67. [Google Scholar] [CrossRef]
- Maia, J.; Fonseca, B.M.; Teixeira, N.; Correia-Da-Silva, G. The Fundamental Role of the Endocannabinoid System in Endometrium and Placenta: Implications in Pathophysiological Aspects of Uterine and Pregnancy Disorders. Hum. Reprod. Update 2020, 26, 586–602. [Google Scholar] [CrossRef]
- Fonseca, B.M.; Cunha, S.C.; Gonçalves, D.; Mendes, A.; Braga, J.; Correia-Da-Silva, G.; Teixeira, N.A. Decidual NK Cell-Derived Conditioned Medium from Miscarriages Affects Endometrial Stromal Cell Decidualisation: Endocannabinoid Anandamide and Tumour Necrosis Factor-α Crosstalk. Hum. Reprod. 2020, 35, 265–274. [Google Scholar] [CrossRef]
- Almada, M.; Amaral, C.; Diniz-Da-Costa, M.; Correia-Da-Silva, G.; Teixeira, N.A.; Fonseca, B.M. The Endocannabinoid Anandamide Impairs in Vitro Decidualization of Human Cells. Reproduction 2016, 152, 351–361. [Google Scholar] [CrossRef]
- Walker, O.S.; Ragos, R.; Gurm, H.; Lapierre, M.; May, L.L.; Raha, S. Delta-9-Tetrahydrocannabinol Disrupts Mitochondrial Function and Attenuates Syncytialization in Human Placental BeWo Cells. Physiol. Rep. 2020, 8, 1–17. [Google Scholar] [CrossRef] [PubMed]
- Vučkovic, S.; Srebro, D.; Vujovic, K.S.; Vučetic, Č.; Prostran, M. Cannabinoids and Pain: New Insights from Old Molecules. Front. Pharmacol. 2018, 9, 1–19. [Google Scholar] [CrossRef] [Green Version]
- Starkey, P.M.; Sargent, I.L.; Redman, C.W. Cell Populations in Human Early Pregnancy Decidua: Characterization and Isolation of Large Granular Lymphocytes by Flow Cytometry. Immunology 1988, 65, 129–134. [Google Scholar]
- Lanier, L.L.; Le, A.M.; Civin, C.I.; Loken, M.R.; Phillips, J.H. The Relationship of CD16 (Leu-11) and Leu-19 (NKH-1) Antigen Expression on Human Peripheral Blood NK Cells and Cytotoxic T Lymphocytes. J. Immunol. 1986, 136, 4480–4486. [Google Scholar]
- Cooper, M.A.; Fehniger, T.A.; Caligiuri, M.A. The Biology of Human Natural Killer-Cell Subsets. Trends Immunol. 2001, 22, 633–640. [Google Scholar] [CrossRef]
- King, A.; Wooding, P.; Gardner, L.; Loke, Y.W. Immunology: Expression of Perforin, Granzyme a and TIA-1 by Human Uterine CD56+ NK Cells Implies They Are Activated and Capable of Effector Functions. Hum. Reprod. 1993, 8, 2061–2067. [Google Scholar] [CrossRef]
- Koopman, L.A.; Kopcow, H.D.; Rybalov, B.; Boyson, J.E.; Orange, J.S.; Schatz, F.; Masch, R.; Lockwood, C.J.; Schachter, A.D.; Park, P.J.; et al. Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential. J. Exp. Med. 2003, 198, 1201–1212. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gong, H.; Chen, Y.; Xu, J.; Xie, X.; Yu, D.; Yang, B.; Kuang, H. The Regulation of Ovary and Conceptus on the Uterine Natural Killer Cells during Early Pregnancy. Reprod. Biol. Endocrinol. 2017, 15, 1–10. [Google Scholar] [CrossRef] [Green Version]
- Manaseki, S.; Searle, R.F. Natural Killer (NK) Cell Activity of First Trimester Human Decidua. Cell. Immunol. 1989, 121, 166–173. [Google Scholar] [CrossRef]
- Faas, M.M.; de Vos, P. Uterine NK Cells and Macrophages in Pregnancy. Placenta 2017, 56, 44–52. [Google Scholar] [CrossRef]
- Clifford, K.; Flanagan, A.M.; Regan, L. Endometrial CD56 + Natural Killer Cells in Women with Recurrent Miscarriage: A Histomorphometric Study. Hum. Reprod. 1999, 14, 2727–2730. [Google Scholar] [CrossRef] [Green Version]
- Quenby, S.; Bates, M.; Doig, T.; Brewster, J.; Lewis-Jonesn, D.I.; Johnson, P.M.; Vince, G. Pre-Implantation Endometrial Leukocytes in Women with Recurrent Miscarriage. Hum. Reprod. 1999. [Google Scholar] [CrossRef]
- Tuckerman, E.; Laird, S.M.; Prakash, A.; Li, T.C. Prognostic Value of the Measurement of Uterine Natural Killer Cells in the Endometrium of Women with Recurrent Miscarriage. Hum. Reprod. 2007, 22, 2208–2213. [Google Scholar] [CrossRef] [PubMed]
- Stallmach, T.; Hebisch, G.; Orban, P.; Lü, X. Aberrant Positioning of Trophoblast and Lymphocytes in the Feto-Maternal Interface with Pre-Eclampsia. Virchows Arch. 1999, 434, 207–211. [Google Scholar] [CrossRef] [PubMed]
- Wilczyński, J.R.; Tchórzewski, H.; Banasik, M.; Głowacka, E.; Wieczorek, A.; Lewkowicz, P.; Malinowski, A.; Szpakowski, M.; Wilczyński, J. Lymphocyte Subset Distribution and Cytokine Secretion in Third Trimester Decidua in Normal Pregnancy and Preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003, 109, 8–15. [Google Scholar] [CrossRef]
- Turco, M.Y.; Moffett, A. Development of the Human Placenta. Development 2019, 146, 1–14. [Google Scholar] [CrossRef] [Green Version]
- Knöfler, M.; Haider, S.; Saleh, L.; Pollheimer, J.; Gamage, T.K.J.B.; James, J. Human Placenta and Trophoblast Development: Key Molecular Mechanisms and Model Systems. Cell. Mol. Life Sci. 2019, 76, 3479–3496. [Google Scholar] [CrossRef] [Green Version]
- Pegram, H.J.; Andrews, D.M.; Smyth, M.J.; Darcy, P.K.; Kershaw, M.H. Activating and Inhibitory Receptors of Natural Killer Cells. Immunol. Cell Biol. 2011, 89, 216–224. [Google Scholar] [CrossRef]
- King, A.; Birkby, C.; Loke, Y.W. Early Human Decidual Cells Exhibit NK Activity against the K562 Cell Line but Not against First Trimester Trophoblast. Cell. Immunol. 1989, 118, 337–344. [Google Scholar] [CrossRef]
- Apps, R.; Murphy, S.P.; Fernando, R.; Gardner, L.; Ahad, T.; Moffett, A. Human Leucocyte Antigen (HLA) Expression of Primary Trophoblast Cells and Placental Cell Lines, Determined Using Single Antigen Beads to Characterize Allotype Specificities of Anti-HLA Antibodies. Immunology 2009, 127, 26–39. [Google Scholar] [CrossRef]
- King, A.; Boocock, C.; Sharkey, A.M.; Gardner, L.; Beretta, A.; Siccardi, A.G.; Yung Wai, L. Evidence for the Expression of HLA-C Class I MRNA and Protein by Human First Trimester Trophoblast. J. Reprod. Immunol. 1996, 31, 232–233. [Google Scholar] [CrossRef]
- Manaster, I.; Mandelboim, O. The Unique Properties of Human NK Cells in the Uterine Mucosa. Placenta 2008, 29, 60–66. [Google Scholar] [CrossRef]
- King, A.; Allan, D.S.J.; Bowen, M.; Powis, S.J.; Joseph, S.; Verma, S.; Hiby, S.E.; McMichael, A.J.; Loke, Y.W.; Braud, V.M. HLA-E Is Expressed on Trophoblast and Interacts with CD94/NKG2 Receptors on Decidual NK Cells. Eur. J. Immunol. 2000, 30, 1623–1631. [Google Scholar] [CrossRef]
- Moffett, A.; Loke, C. Immunology of Placentation in Eutherian Mammals. Nat. Rev. Immunol. 2006, 6, 584–594. [Google Scholar] [CrossRef] [PubMed]
- Rajagopalan, S.; Bryceson, Y.T.; Kuppusamy, S.P.; Geraghty, D.E.; Van Der Meer, A.; Joosten, I.; Long, E.O. Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G. PLoS Biol. 2006, 4, e9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pace, D.; Morrison, L.; Bulmer, J.N. Proliferative Activity in Endometrial Stromal Granulocytes throughout Menstrual Cycle and Early Pregnancy. J. Clin. Pathol. 1989, 42, 35–39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Keskin, D.B.; Allan, D.S.J.; Rybalov, B.; Andzelm, M.M.; Stern, J.N.H.; Kopcow, H.D.; Koopman, L.A.; Strominger, J.L. TGFβ Promotes Conversion of CD16+ Peripheral Blood NK Cells into CD16- NK Cells with Similarities to Decidual NK Cells. Proc. Natl. Acad. Sci. USA 2007, 104, 3378–3383. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hanna, J.; Wald, O.; Goldman-Wohl, D.; Prus, D.; Markel, G.; Gazit, R.; Katz, G.; Haimov-Kochman, R.; Fujii, N.; Yagel, S.; et al. CXCL12 Expression by Invasive Trophoblasts Induces the Specific Migration of CD16- Human Natural Killer Cells. Blood 2003, 102, 1569–1577. [Google Scholar] [CrossRef] [PubMed]
- Hanna, J.; Goldman-Wohl, D.; Hamani, Y.; Avraham, I.; Greenfield, C.; Natanson-Yaron, S.; Prus, D.; Cohen-Daniel, L.; Arnon, T.I.; Manaster, I.; et al. Decidual NK Cells Regulate Key Developmental Processes at the Human Fetal-Maternal Interface. Nat. Med. 2006, 12, 1065–1074. [Google Scholar] [CrossRef] [PubMed]
- Nagase, H.; Woessner, J., Jr. Matrix Metalloproteinases. In Targeted Therapies in Oncology; No. 37; CRC Press: Boca Raton, FL, USA, 2007; pp. 315–332. [Google Scholar] [CrossRef]
- Huppertz, B.; Kertschanska, S.; Demir, A.Y.; Frank, H.G.; Kaufmann, P. Immunohistochemistry of Matrix Metalloproteinases (MMP), Their Substrates, and Their Inhibitors (TIMP) during Trophoblast Invasion in the Human Placenta. Cell Tissue Res. 1997, 291, 133–148. [Google Scholar] [CrossRef]
- Naruse, K.; Lash, G.E.; Innes, B.A.; Otun, H.A.; Searle, R.F.; Robson, S.C.; Bulmer, J.N. Localization of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tissue Inhibitors for MMPs (TIMPs) in Uterine Natural Killer Cells in Early Human Pregnancy. Hum. Reprod. 2009, 24, 553–561. [Google Scholar] [CrossRef] [Green Version]
- Lash, G.E.; Otun, H.A.; Innes, B.A.; Percival, K.; Searle, R.F.; Robson, S.C.; Bulmer, J.N. Regulation of Extravillous Trophoblast Invasion by Uterine Natural Killer Cells Is Dependent on Gestational Age. Hum. Reprod. 2010, 25, 1137–1145. [Google Scholar] [CrossRef] [Green Version]
- Li, X.F.; Charnock-jones, D.S.; Zhang, E.K.O.; Hiby, S.; Malik, S.; Day, K.; Licence, D.; Bowen, J.M.; Gardner, L.; King, A.; et al. In Uterine Natural Killer Cells. Front. Immunol. 2001, 86, 960. [Google Scholar]
- Naruse, K.; Innes, B.A.; Bulmer, J.N.; Robson, S.C.; Searle, R.F.; Lash, G.E. Secretion of Cytokines by Villous Cytotrophoblast and Extravillous Trophoblast in the First Trimester of Human Pregnancy. J. Reprod. Immunol. 2010, 86, 148–150. [Google Scholar] [CrossRef] [PubMed]
- Ferrara, N.; Gerber, H.P.; LeCouter, J. The Biology of VEGF and Its Receptors. Nat. Med. 2003, 9, 669–676. [Google Scholar] [CrossRef] [PubMed]
- Smith, S.D.; Dunk, C.E.; Aplin, J.D.; Harris, L.K.; Jones, R.L. Evidence for Immune Cell Involvement in Decidual Spiral Arteriole Remodeling in Early Human Pregnancy. Am. J. Pathol. 2009, 174, 1959–1971. [Google Scholar] [CrossRef] [Green Version]
- Craven, C.M.; Morgan, T.; Ward, K. Decidual Spiral Artery Remodelling Begins before Cellular Interaction with Cytotrophoblasts. Placenta 1998, 19, 241–252. [Google Scholar] [CrossRef]
- Hernández-Cervantes, R.; Méndez-DÍaz, M.; Prospéro-García, Ó.; Morales-Montor, J. Immunoregulatory Role of Cannabinoids during Infectious Disease. Neuroimmunomodulation 2018, 24, 183–199. [Google Scholar] [CrossRef] [PubMed]
- Bouaboula, M.; Rinaldi, M.; Carayon, P.; Carillon, C.; Delpech, B.; Shire, D.; Le Fur, G.; Casellas, P. Cannabinoid-receptor Expression in Human Leukocytes. Eur. J. Biochem. 1993, 214, 173–180. [Google Scholar] [CrossRef]
- Galiègue, S.; Mary, S.; Marchand, J.; Dussossoy, D.; Carrière, D.; Carayon, P.; Bouaboula, M.; Shire, D.; LE Fur, G.; Casellas, P. Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations. Eur. J. Biochem. 1995, 232, 54–61. [Google Scholar] [CrossRef]
- Matias, I.; Pochard, P.; Orlando, P.; Salzet, M.; Pestel, J.; Di Marzo, V. Presence and Regulation of the Endocannabinoid System in Human Dendritic Cells. Eur. J. Biochem. 2002, 269, 3771–3778. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Di Marzo, V.; Bisogno, T.; De Petrocellis, L.; Melck, D.; Orlando, P.; Wagner, J.A.; George, K. Biosynthesis and Inactivation of the Endocannabinoid 2-Arachidonoylglycerol in Circulating and Tumoral Macrophages. Eur. J. Biochem. 1999, 264, 258–267. [Google Scholar] [CrossRef]
- Maccarrone, M.; Bari, M.; Battista, N.; Finazzi-Agrò, A. Endocannabinoid Degradation, Endotoxic Shock and Inflammation. Curr. Drug Targets Inflamm. Allergy 2002, 1, 53–63. [Google Scholar] [CrossRef] [PubMed]
- Do, Y.; McKallip, R.J.; Nagarkatti, M.; Nagarkatti, P.S. Activation through Cannabinoid Receptors 1 and 2 on Dendritic Cells Triggers NF-ΚB-Dependent Apoptosis: Novel Role for Endogenous and Exogenous Cannabinoids in Immunoregulation. J. Immunol. 2004, 173, 2373–2382. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maestroni, G.J.M. The Endogenous Cannabinoid 2-arachidonoyl Glycerol as in Vivo Chemoattractant for Dendritic Cells and Adjuvant for Th1 Response to a Soluble Protein. FASEB J. 2004, 18, 1914–1916. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- McHugh, D.; Tanner, C.; Mechoulam, R.; Pertwee, R.G.; Ross, R.A. Inhibition of Human Neutrophil Chemotaxis by Endogenous Cannabinoids and Phytocannabinoids: Evidence for a Site Distinct from CB1 and CB 2. Mol. Pharmacol. 2008, 73, 441–450. [Google Scholar] [CrossRef]
- Cabral, G.A.; Toney, D.M.; Fischer-Stenger, K.; Harrison, M.P.; Marciano-Cabral, F. Anandamide Inhibits Macrophage-Mediated Killing of Tumor Necrosis Factor-Sensitive Cells. Life Sci. 1995, 56, 2065–2072. [Google Scholar] [CrossRef]
- Gallily, R.; Breuer, A.; Mechoulam, R. 2-Arachidonylglycerol, an Endogenous Cannabinoid, Inhibits Tumor Necrosis Factor-α Production in Murine Macrophages, and in Mice. Eur. J. Pharmacol. 2000, 406, 1997–1999. [Google Scholar] [CrossRef]
- Specter, S.C.; Klein, T.W.; Newton, C.; Mondragon, M.; Widen, R.; Friedman, H. Marijuana Effects on Immunity: Suppression of Human Natural Killer Cell Activity by Delta-9-Tetrahydrocannabinol. Int. J. Immunopharmacol. 1986, 8, 741–745. [Google Scholar] [CrossRef]
- Mccoy, K.L. Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation. Mediat. Inflamm. 2016, 2016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xu, H.; Cheng, C.L.; Chen, M.; Manivannan, A.; Cabay, L.; Pertwee, R.G.; Coutts, A.; Forrester, J.V. Anti-Inflammatory Property of the Cannabinoid Receptor-2-Selective Agonist JWH-133 in a Rodent Model of Autoimmune Uveoretinitis. J. Leukoc. Biol. 2007, 82, 532–541. [Google Scholar] [CrossRef]
- Jeon, Y.J.; Yang, K.H.; Pulaski, J.T.; Kaminski, N.E. Attenuation of Inducible Nitric Oxide Synthase Gene Expression by Δ9- Tetrahydrocannabinol Is Mediated through the Inhibition of Nuclear Factor- ΚB/Rel Activation. Mol. Pharmacol. 1996, 50, 334–341. [Google Scholar]
- Tanikawa, T.; Kurohane, K.; Imai, Y. Induction of Preferential Chemotaxis of Unstimulated B-Lymphocytes by 2-Arachidonoylglycerol in Immunized Mice. Microbiol. Immunol. 2007, 51, 1013–1019. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pereira, J.P.; An, J.; Xu, Y.; Huang, Y.; Cyster, J.G. Cannabinoid Receptor 2 Mediates the Retention of Immature B Cells in Bone Marrow Sinusoids. Nat. Immunol. 2009, 10, 403–411. [Google Scholar] [CrossRef]
- Agudelo, M.; Newton, C.; Widen, R.; Sherwood, T.; Nong, L.; Friedman, H.; Klein, T.W. Cannabinoid Receptor 2 (CB2) Mediates Immunoglobulin Class Switching from IgM to IgE in Cultures of Murine-Purified B Lymphocytes. J. NeuroImmune Pharmacol. 2008, 3, 35–42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cencioni, M.T.; Chiurchiù, V.; Catanzaro, G.; Borsellino, G.; Bernardi, G.; Battistini, L.; Maccarrone, M. Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors. PLoS ONE 2010, 5, e8688. [Google Scholar] [CrossRef] [PubMed]
- Joseph, J.; Niggemann, B.; Zaenker, K.S.; Entschladen, F. Anandamide Is an Endogenous Inhibitor for the Migration of Tumor Cells and T Lymphocytes. Cancer Immunol. Immunother. 2004, 53, 723–728. [Google Scholar] [CrossRef] [PubMed]
- Yuan, M.; Kiertscher, S.M.; Cheng, Q.; Zoumalan, R.; Tashkin, D.P.; Roth, M.D. Δ9-Tetrahydrocannabinol Regulates Th1/Th2 Cytokine Balance in Activated Human T Cells. J. Neuroimmunol. 2002, 133, 124–131. [Google Scholar] [CrossRef]
- Battista, N.; Bari, M.; Maccarrone, M. Endocannabinoids and Reproductive Events in Health and Disease; Pertwee, R.G., Ed.; Springer International Publishing: Aberdeen, UK, 2013. [Google Scholar] [CrossRef]
- Walker, O.L.S.; Holloway, A.C.; Raha, S. The Role of the Endocannabinoid System in Female Reproductive Tissues. J. Ovarian Res. 2019, 12, 1–10. [Google Scholar] [CrossRef]
- Habayeb, O.M.H.; Taylor, A.H.; Evans, M.D.; Cooke, M.S.; Taylor, D.J.; Bell, S.C.; Konje, J.C. Plasma Levels of the Endocannabinoid Anandamide in Women-A Potential Role in Pregnancy Maintenance and Labor? J. Clin. Endocrinol. Metab. 2004, 89, 5482–5487. [Google Scholar] [CrossRef] [Green Version]
- Paria, B.C.; Ma, W.; Andrenyak, D.M.; Schmid, P.C.; Schmid, H.H.O.; Moody, D.E.; Deng, H.; Makriyannis, A.; Dey, S.K. Effects of Cannabinoids on Preimplantation Mouse Embryo Development and Implantation Are Mediated by Brain-Type Cannabinoid Receptors. Biol. Reprod. 1998, 58, 1490–1495. [Google Scholar] [CrossRef] [Green Version]
- Ander, S.E.; Diamond, M.S.; Coyne, C.B. Immune Responses at the Maternal-Fetal Interface. Sci. Immunol. 2019, 4. [Google Scholar] [CrossRef]
- Helliwell, R.J.A.; Chamley, L.W.; Blake-Palmer, K.; Mitchell, M.D.; Wu, J.; Kearn, C.S.; Glass, M. Characterization of the Endocannabinoid System in Early Human Pregnancy. J. Clin. Endocrinol. Metab. 2004, 89, 5168–5174. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Taylor, A.H.; Finney, M.; Lam, P.M.W.; Konje, J.C. Modulation of the Endocannabinoid System in Viable and Non-Viable First Trimester Pregnancies by Pregnancy-Related Hormones. Reprod. Biol. Endocrinol. 2011, 9, 152. [Google Scholar] [CrossRef] [Green Version]
- Abán, C.E.; Accialini, P.L.; Etcheverry, T.; Leguizamón, G.F.; Martinez, N.A.; Farina, M.G. Crosstalk Between Nitric Oxide and Endocannabinoid Signaling Pathways in Normal and Pathological Placentation. Front. Physiol. 2018, 9, 1–9. [Google Scholar] [CrossRef] [PubMed]
- Costa, M.A.; Fonseca, B.M.; Keating, E.; Teixeira, N.A.; Correia-Da-Silva, G. 2-Arachidonoylglycerol Effects in Cytotrophoblasts: Metabolic Enzymes Expression and Apoptosis in BeWo Cells. Reproduction 2014, 147, 301–311. [Google Scholar] [CrossRef] [PubMed]
- Costa, M.A.; Keating, E.; Fonseca, B.M.; Teixeira, N.A.; Correia-da-Silva, G. 2-Arachidonoylglycerol Impairs Human Cytotrophoblast Cells Syncytialization: Influence of Endocannabinoid Signalling in Placental Development. Mol. Cell. Endocrinol. 2015, 399, 386–394. [Google Scholar] [CrossRef]
- Costa, M.A.; Fonseca, B.M.; Teixeira, N.A.; Correia-Da-Silva, G. The Endocannabinoid Anandamide Induces Apoptosis in Cytotrophoblast Cells: Involvement of Both Mitochondrial and Death Receptor Pathways. Placenta 2015, 36, 69–76. [Google Scholar] [CrossRef]
- Chang, X.; Bian, Y.; He, Q.; Yao, J.; Zhu, J.; Wu, J.; Wang, K.; Duan, T. Suppression of STAT3 Signaling by Δ 9 -Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction. Cell. Physiol. Biochem. 2017, 42, 537–550. [Google Scholar] [CrossRef]
- Fonseca, B.M.; Correia-Da-Silva, G.; Almada, M.; Costa, M.A.; Teixeira, N.A. The Endocannabinoid System in the Postimplantation Period: A Role during Decidualization and Placentation. Int. J. Endocrinol. 2013, 2013. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kessler, C.A.; Moghadam, K.K.; Schroeder, J.K.; Buckley, A.R.; Brar, A.K.; Handwerger, S. Cannabinoid Receptor I Activation Markedly Inhibits Human Decidualization. Mol. Cell. Endocrinol. 2005, 229, 65–74. [Google Scholar] [CrossRef]
- Telgmann, R.; Maronde, E.; Taskén, K.; Gellersen, B. Activated Protein Kinase A Is Required for Differentiation-Dependent Transcription of the Decidual Prolactin Gene in Human Endometrial Stromal Cells. Endocrinology 1997, 138, 929–937. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.; Wang, Y.; Wang, X.H.; Zhou, W.J.; Jin, L.P.; Li, M.Q. Crosstalk between Human Endometrial Stromal Cells and Decidual NK Cells Promotes Decidualization in Vitro by Upregulating IL-25. Mol. Med. Rep. 2018, 17, 2869–2878. [Google Scholar] [CrossRef] [Green Version]
- Gellersen, B.; Brosens, J. Cyclic AMP and Progesterone Receptor Cross-Talk in Human Endometrium: A Decidualizing Affair. J. Endocrinol. 2003, 178, 357–372. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wallace, A.E.; Fraser, R.; Cartwright, J.E. Extravillous Trophoblast and Decidual Natural Killer Cells: A Remodelling Partnership. Hum. Reprod. Update 2012, 18, 458–471. [Google Scholar] [CrossRef] [Green Version]
- Wang, Y.; Zhang, Y.; Li, M.Q.; Fan, D.X.; Wang, X.H.; Li, D.J.; Jin, L.P. Interleukin-25 Induced by Human Chorionic Gonadotropin Promotes the Proliferation of Decidual Stromal Cells by Activation of JNK and AKT Signal Pathways. Fertil. Steril. 2014, 102, 257–263. [Google Scholar] [CrossRef]
- King, A.; Jokhi, P.P.; Smith, S.K.; Sharkey, A.M. Screening for Cytokine MRNA in Villous and Extravillous Trophoblasts Using the Reverse Transcriptase Polymerase Chain Reaction (RT-PCR). Cytokine 1995, 7, 364–371. [Google Scholar] [CrossRef] [PubMed]
- Thathiah, A.; Brayman, M.; Dharmaraj, N.; Julian, J.A.J.; Lagow, E.L.; Carson, D.D. Tumor Necrosis Factor α Stimulates MUC1 Synthesis and Ectodomain Release in a Human Uterine Epithelial Cell Line. Endocrinology 2004, 145, 4192–4203. [Google Scholar] [CrossRef] [PubMed]
- Fukushima, K.; Miyamoto, S.; Komatsu, H.; Tsukimori, K.; Kobayashi, H.; Seki, H.; Takeda, S.; Nakano, H. TNFα-Induced Apoptosis and Integrin Switching in Human Extravillous Trophoblast Cell Line. Biol. Reprod. 2003, 68, 1771–1778. [Google Scholar] [CrossRef]
- Yui, J.; Garcia-Lloret, M.; Wegmann, T.G.; Guilbert, L.J. Cytotoxicity of Tumour Necrosis Factor-Alpha and Gamma-Interferon against Primary Human Placental Trophoblasts. Placenta 1994, 15, 819–835. [Google Scholar] [CrossRef]
- Bauer, S.; Pollheimer, J.; Hartmann, J.; Husslein, P.; Aplin, J.D.; Knöfler, M. Tumor Necrosis Factor-α Inhibits Trophoblast Migration through Elevation of Plasminogen Activator Inhibitor-1 in First-Trimester Villous Explant Cultures. J. Clin. Endocrinol. Metab. 2004, 89, 812–822. [Google Scholar] [CrossRef] [PubMed]
- Inoue, T.; Kanzaki, H.; Iwai, M.; Imai, K.; Narukawa, S.; Higuchi, T.; Katsuragawa, H.; Mori, T. Implantation: Tumour Necrosis Factor α Inhibits in-Vitro Decidualization of Human Endometrial Stromal Cells. Hum. Reprod. 1994, 9, 2411–2417. [Google Scholar] [CrossRef]
- Shobokshi, A.; Shaarawy, M. Maternal Serum and Amniotic Fluid Cytokines in Patients with Preterm Premature Rupture of Membranes with and without Intrauterine Infection. Int. J. Gynecol. Obstet. 2002, 79, 209–215. [Google Scholar] [CrossRef]
- Tosun, M.; Celik, H.; Avci, B.; Yavuz, E.; Alper, T.; Malatyalioǧlu, E. Maternal and Umbilical Serum Levels of Interleukin-6, Interleukin-8, and Tumor Necrosis Factor-α in Normal Pregnancies and in Pregnancies Complicated by Preeclampsia. J. Matern. Neonatal Med. 2010, 23, 880–886. [Google Scholar] [CrossRef]
- Giannubilo, S.R.; Landi, B.; Pozzi, V.; Sartini, D.; Cecati, M.; Stortoni, P.; Corradetti, A.; Saccucci, F.; Tranquilli, A.L.; Emanuelli, M. The Involvement of Inflammatory Cytokines in the Pathogenesis of Recurrent Miscarriage. Cytokine 2012, 58, 50–56. [Google Scholar] [CrossRef] [PubMed]
- Corsi, D.J.; Walsh, L.; Weiss, D.; Hsu, H.; El-Chaar, D.; Hawken, S.; Fell, D.B.; Walker, M. Association Between Self-Reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes Title. JAMA 2019, 322, 145–152. [Google Scholar] [CrossRef] [PubMed]
- Bartlett, K.; Kaarid, K.; Gervais, N.; Vu, N.; Sharma, S.; Patel, T.; Shea, A.K. Pregnant Canadians’ Perceptions About the Transmission of Cannabis in Pregnancy and While Breastfeeding and the Impact of Information From Health Care Providers on Discontinuation of Use. J. Obstet. Gynaecol. Canada 2020, 42, 1346–1350. [Google Scholar] [CrossRef] [PubMed]
- Young-Wolff, K.C.; Tucker, L.; Alexeeff, S.; Anne, M.; Conway, A.; Weisner, C.; Goler, N. Among Pregnant Females in California from 2009–2016. JAMA 2018, 318, 2490–2491. [Google Scholar] [CrossRef]
- Goldschmidt, L.; Richardson, G.A.; Cornelius, M.D.; Day, N.L. Prenatal Marijuana and Alcohol Exposure and Academic Achievement at Age 10. Neurotoxicol. Teratol. 2004, 26, 521–532. [Google Scholar] [CrossRef]
- Badowski, S.; Smith, G. Cannabis Use during Pregnancy and Postpartum. Can. Fam. Physician 2020, 66, 98–103. [Google Scholar]
- Flament, J.; Scius, N.; Thonon, H. Cannabinoid Hyperemesis Syndrome in the Pregnant Patient: Clinical Case and Literature Review. Int. J. Emerg. Med. 2020, 13, 1–4. [Google Scholar] [CrossRef]
- Friedrich, J.; Khatib, D.; Parsa, K.; Santopietro, A.; Gallicano, G.I. The Grass Isn’t Always Greener: The Effects of Cannabis on Embryological Development. BMC Pharmacol. Toxicol. 2016, 17, 1–13. [Google Scholar] [CrossRef] [Green Version]
- Ryan, S.A.; Ammerman, S.D.; O’Connor, M.E.; Patrick, S.W.; Plumb, J.; Quigley, J.; Walker-Harding, L.R. Marijuana Use during Pregnancy and Breastfeeding: Implications for Neonatal and Childhood Outcomes. Pediatrics 2018, 142. [Google Scholar] [CrossRef] [Green Version]
- Ko, J.Y.; Farr, S.L.; Tong, V.T.; Creanga, A.A.; Callaghan, W.M. Prevalence and Patterns of Marijuana Use among Pregnant and Nonpregnant Women of Reproductive Age. Am. J. Obstet. Gynecol. 2015, 213, 201.e1–201.e10. [Google Scholar] [CrossRef] [PubMed]
- Hutchings, D.E.; Martin, B.R.; Gamagaris, Z.; Miller, N.; Fico, T. Plasma Concentrations of Delta-9-Tetrahydrocannabinol in Dams and Fetuses Following Acute or Multiple Prenatal Dosing in Rats. Life Sci. 1989, 44, 697–701. [Google Scholar] [CrossRef]
- Bailey, J.R.; Cunny, H.C.; Paule, M.G.; Slikker, W. Fetal Disposition of Δ9-Tetrahydrocannabinol (THC) during Late Pregnancy in the Rhesus Monkey. Toxicol. Appl. Pharmacol. 1987, 90, 315–321. [Google Scholar] [CrossRef]
- Grant, K.S.; Petroff, R.; Isoherranen, N.; Stella, N.; Burbacher, T.M. Cannabis Use during Pregnancy: Pharmacokinetics and Effects on Child Development. Pharmacol. Ther. 2018, 182, 133–151. [Google Scholar] [CrossRef]
- Iwamura, H.; Suzuki, H.; Ueda, Y.; Kaya, T.; Inaba, T. In Vitro and in Vivo Pharmacological Characterization of JTE-907, a Novel Selective Ligand for Cannabinoid CB2 Receptor. J. Pharmacol. Exp. Ther. 2001, 296, 420–425. [Google Scholar]
- Pertwee, R.G. The Diverse CB1 and CB2 Receptor Pharmacology of Three Plant Cannabinoids: Δ 9-Tetrahydrocannabinol, Cannabidiol and Δ 9-Tetrahydrocannabivarin. Br. J. Pharmacol. 2008, 153, 199–215. [Google Scholar] [CrossRef] [Green Version]
- Showalter, V.M.; Compton, D.R.; Martin, B.R.; Abood, M.E. Evaluation of Binding in a Transfected Cell Line Expressing a Peripheral Cannabinoid Receptor (CB2): Identification of Cannabinoid Receptor Subtype Selective Ligands. J. Pharmacol. Exp. Ther. 1996, 278, 989–999. [Google Scholar] [PubMed]
- Steffens, M.; Zentner, J.; Honegger, J.; Feuerstein, T.J. Binding Affinity and Agonist Activity of Putative Endogenous Cannabinoids at the Human Neocortical CB1 Receptor. Biochem. Pharmacol. 2005, 69, 169–178. [Google Scholar] [CrossRef] [PubMed]
- Felder, C.C.; Joyce, K.E.; Briley, E.M.; Mansouri, J.; Mackie, K.; Blond, O.; Lai, Y.; Ma, A.L.; Mitchell, R.L. Comparison of the Pharmacology and Signal Transduction of the Human Cannabinoid CB1 and CB2 Receptors. Mol. Pharmacol. 1995, 48, 443–450. [Google Scholar]
- Ben-Shabat, S.; Fride, E.; Sheskin, T.; Tamiri, T.; Rhee, M.H.; Vogel, Z.; Bisogno, T.; De Petrocellis, L.; Di Marzo, V.; Mechoulam, R. An Entourage Effect: Inactive Endogenous Fatty Acid Glycerol Esters Enhance 2-Arachidonoyl-Glycerol Cannabinoid Activity. Eur. J. Pharmacol. 1998, 353, 23–31. [Google Scholar] [CrossRef]
- Kano, M.; Ohno-Shosaku, T.; Maejima, T. Retrograde Signaling at Central Synapses via Endogenous Cannabinoids. Mol. Psychiatry 2002, 7, 234–235. [Google Scholar] [CrossRef] [PubMed]
- Iversen, L. Cannabis and the Brain. Brain 2003, 126, 1252–1270. [Google Scholar] [CrossRef] [Green Version]
- Stasiulewicz, A.; Znajdek, K.; Grudzień, M.; Pawiński, T.; Sulkowska, J.I. A Guide to Targeting the Endocannabinoid System in Drug Design. Int. J. Mol. Sci. 2020, 21, 2778. [Google Scholar] [CrossRef]
- Pi-Sunyer, F.X.; Aronne, L.J.; Devin, J.; Rosenstock, J. Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients-RIO-North America: A Randomized Controlled Trial. JAMA 2007, 295, 761–776. [Google Scholar] [CrossRef] [Green Version]
- Xia, L.; de Vries, H.; Yang, X.; Lenselink, E.B.; Kyrizaki, A.; Barth, F.; Louvel, J.; Dreyer, M.K.; van der Es, D.; IJzerman, A.P.; et al. Kinetics of Human Cannabinoid 1 (CB1) Receptor Antagonists: Structure-Kinetics Relationships (SKR) and Implications for Insurmountable Antagonism. Biochem. Pharmacol. 2018, 151, 166–179. [Google Scholar] [CrossRef] [PubMed]
- Sam, A.H.; Salem, V.; Ghatei, M.A. Rimonabant: From RIO to Ban. J. Obes. 2011, 2011. [Google Scholar] [CrossRef]
- Smith, J.S.; Lefkowitz, R.J.; Rajagopal, S. Biased Signalling: From Simple Switches to Allosteric Microprocessors. Nat. Rev. Drug Discov. 2018, 17, 243–260. [Google Scholar] [CrossRef] [PubMed]
- Drug Trials Snapshots: Epidiolex|FDA. Available online: https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-epidiolex (accessed on 16 December 2020).
- FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)|FDA. Available online: https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd (accessed on 16 December 2020).
- Hanan, A.P.D.; Sophie-Anne, L.; George, M.P.D. Information for Health Care Professionals: Cannabis (Marihuana, Marijuana) and the Cannabinoids. Available online: https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/information-medical-practitioners/information-health-care-professionals-cannabis-cannabinoids.html#authorship (accessed on 16 December 2020).
- Alves, V.L.; Gonçalves, J.L.; Aguiar, J.; Teixeira, H.M.; Câmara, J.S. The Synthetic Cannabinoids Phenomenon: From Structure to Toxicological Properties. A Review. Crit. Rev. Toxicol. 2020, 50, 359–382. [Google Scholar] [CrossRef]
- Pergolizzi, J.V.; Taylor, R.; LeQuang, J.A.; Zampogna, G.; Raffa, R.B. Concise Review of the Management of Iatrogenic Emesis Using Cannabinoids: Emphasis on Nabilone for Chemotherapy-Induced Nausea and Vomiting. Cancer Chemother. Pharmacol. 2017, 79, 467–477. [Google Scholar] [CrossRef]
- Borison, H.; Wang, S. Physiology and Pharmacology of Vomiting. Drugs 1953, 5, 193–230. [Google Scholar]
- Liano, H.C.; Zakowicz, P.; Mikołajczak, P. Cannabinoids as Antiemetics: A Short Review. Acta Pol. Pharm.-Drug Res. 2018, 75, 1063–1068. [Google Scholar] [CrossRef]
- Darmani, N.A. Δ9-Tetrahydrocannabinol and Synthetic Cannabinoids Prevent Emesis Produced by the Cannabinoid CB1 Receptor Antagonist/Inverse Agonist SR 141716A. Neuropsychopharmacology 2001, 24, 198–203. [Google Scholar] [CrossRef] [Green Version]
- Gareau, Y.; Dufresne, C.; Gallant, M.; Rochette, C.; Sawyer, N.; Slipetz, D.M.; Tremblay, N.; Weech, P.K.; Metters, K.M.; Labelle, M. Structure Activity Relationships of Tetrahydrocannabinol Analogues on Human Cannabinoid Receptors. Bioorganic. Med. Chem. Lett. 1996, 6, 189–194. [Google Scholar] [CrossRef]
- Lemberger, L.; Rubin, A.; Wolen, R.; DeSante, K.; Rowe, H.; Forney, R.; Pence, P. Pharmacokinetics, Metabolism and Drug-Abuse Potential of Nabilone. Cancer Treat. Rev. 1982, 9, 17–23. [Google Scholar] [CrossRef]
- Heuberger, J.A.A.C.; Guan, Z.; Oyetayo, O.O.; Klumpers, L.; Morrison, P.D.; Beumer, T.L.; van Gerven, J.M.A.; Cohen, A.F.; Freijer, J. Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-Term Pharmacokinetics. Clin. Pharmacokinet. 2015, 54, 209–219. [Google Scholar] [CrossRef]
- Parikh, N.; Kramer, W.G.; Khurana, V.; Cognata Smith, C.; Vetticaden, S. Bioavailability Study of Dronabinol Oral Solution versus Dronabinol Capsules in Healthy Volunteers. Clin. Pharmacol. Adv. Appl. 2016, 8, 155–162. [Google Scholar] [CrossRef] [Green Version]
- Mattes, R.D.; Engelman, K.; Shaw, L.M.; Elsohly, M.A. Cannabinoids and Appetite Stimulation. Pharmacol. Biochem. Behav. 1994, 49, 187–195. [Google Scholar] [CrossRef]
- Morton, G.J.; Cummings, D.E.; Baskin, D.G.; Barsh, G.S.; Schwartz, M.W. Central Nervous System Control of Food Intake and Body Weight. Nature 2006, 443, 289–295. [Google Scholar] [CrossRef]
- Di Marzo, V.; Ligresti, A.; Cristino, L. The Endocannabinoid System as a Link between Homoeostatic and Hedonic Pathways Involved in Energy Balance Regulation. Int. J. Obes. 2009, 33, S18–S24. [Google Scholar] [CrossRef] [Green Version]
- Cheung, K.A.K.; Peiris, H.; Wallace, G.; Holland, O.J.; Mitchell, M.D. The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids. Int. J. Mol. Sci. 2019, 20, 6079. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- De Petrocellis, L.; Ligresti, A.; Moriello, A.S.; Allarà, M.; Bisogno, T.; Petrosino, S.; Stott, C.G.; Di Marzo, V. Effects of Cannabinoids and Cannabinoid-Enriched Cannabis Extracts on TRP Channels and Endocannabinoid Metabolic Enzymes. Br. J. Pharmacol. 2011, 163, 1479–1494. [Google Scholar] [CrossRef] [Green Version]
- Iannotti, F.A.; Hill, C.L.; Leo, A.; Alhusaini, A.; Soubrane, C.; Mazzarella, E.; Russo, E.; Whalley, B.J.; Di Marzo, V.; Stephens, G.J. Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability. ACS Chem. Neurosci. 2014, 5, 1131–1141. [Google Scholar] [CrossRef] [Green Version]
- Gray, R.A.; Whalley, B.J. The Proposed Mechanisms of Action of CBD in Epilepsy. Epileptic Disord. 2020, 22, S10–S15. [Google Scholar] [CrossRef]
- Darkovska-Serafimovska, M.; Serafimovska, T.; Arsova-Sarafinovska, Z.; Stefanoski, S.; Keskovski, Z.; Balkanov, T. Pharmacotherapeutic Considerations for Use of Cannabinoids to Relieve Pain in Patients with Malignant Diseases. J. Pain Res. 2018, 11, 837–842. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Russo, M.; Calabrò, R.S.; Naro, A.; Sessa, E.; Rifici, C.; D’Aleo, G.; Leo, A.; De Luca, R.; Quartarone, A.; Bramanti, P. Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation. Neural Plast. 2015, 2015. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zachariou, M.; Alexander, S.P.H.; Coombes, S.; Christodoulou, C. A Biophysical Model of Endocannabinoid-Mediated Short Term Depression in Hippocampal Inhibition. PLoS ONE 2013, 8, e58926. [Google Scholar] [CrossRef]
- Rea, K.; Roche, M.; Finn, D.P. Supraspinal Modulation of Pain by Cannabinoids: The Role of GABA and Glutamate. Br. J. Pharmacol. 2007, 152, 633–648. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gurm, H.; Hirota, J.A.; Raha, S. Cannabinoid Signalling in Immune–Reproductive Crosstalk during Human Pregnancy. Biomedicines 2021, 9, 267. https://doi.org/10.3390/biomedicines9030267
Gurm H, Hirota JA, Raha S. Cannabinoid Signalling in Immune–Reproductive Crosstalk during Human Pregnancy. Biomedicines. 2021; 9(3):267. https://doi.org/10.3390/biomedicines9030267
Chicago/Turabian StyleGurm, Harmeet, Jeremy A. Hirota, and Sandeep Raha. 2021. "Cannabinoid Signalling in Immune–Reproductive Crosstalk during Human Pregnancy" Biomedicines 9, no. 3: 267. https://doi.org/10.3390/biomedicines9030267